• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

426
71
48
47
24

COUNTRY

46
17
5
5
5

PRICE

292
545
1,153
1,438

PUBLISHED

70
106
472
1,438

PRODUCT TYPE

1,340
67
18
13

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Epilepsy and Brain Tumors Epilepsy and Brain Tumors - Product Thumbnail Image

Epilepsy and Brain Tumors

Patients with brain tumor-related epilepsy (BTRE) suffer from two serious pathologies simultaneously - a brain tumor and a secondary form of epilepsy.  Although there has been remarkable progress in...

April 2015
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

March 2015
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

March 2015
FROM

Perception Journal

Perception is a scholarly journal reporting experimental results and theoretical ideas ranging over the fields of human, animal, and machine perception Topics covered include physiological mechanisms...

March 2015
FROM

Neurological Research

10 issues per year. Neurological Research is an international, peer-reviewed journal for reporting both basic and clinical research in the fields of neurosurgery, neurology, neuroengineering and neurosciences....

March 2015
FROM

Nutritional Neuroscience

"6 issues per year (Online Only). Nutritional Neuroscience is an international, interdisciplinary broad-based journal for reporting both basic and clinical research in the field of nutrition that relates...

March 2015
FROM

Neurotech Business Report

Neurotech Business Report is the first publication targeting the business of neurotechnology, the application of engineering techniques to human neural and information processing systems Each monthly...

March 2015

Neurotech Insights

Covering Drugs, Devices, and Diagnostics for the Brain and Nervous System On the first day of each month, Neurotech Insights is delivered to your inbox giving you competitive intelligence on...

March 2015
FROM
Latuda-Drug Insights,2014 Latuda-Drug Insights,2014 - Product Thumbnail Image

Latuda-Drug Insights,2014

“Latuda - Drug Insights, 2014” provides Latuda marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Xenazine-Drug Insights,2014 Xenazine-Drug Insights,2014 - Product Thumbnail Image

Xenazine-Drug Insights,2014

“Xenazine - Drug Insights, 2014” provides Xenazine marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Neurontin-Drug Insights,2014 Neurontin-Drug Insights,2014 - Product Thumbnail Image

Neurontin-Drug Insights,2014

“Neurontin - Drug Insights, 2014” provides Neurontin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Requip IR-Drug Insights,2014 Requip IR-Drug Insights,2014 - Product Thumbnail Image

Requip IR-Drug Insights,2014

“Requip IR - Drug Insights, 2014” provides Requip IR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Subridion-Drug Insights,2014 Subridion-Drug Insights,2014 - Product Thumbnail Image

Subridion-Drug Insights,2014

“Subridion - Drug Insights, 2014” provides Subridion marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Xanax-Drug Insights,2014 Xanax-Drug Insights,2014 - Product Thumbnail Image

Xanax-Drug Insights,2014

“Xanax XR - Drug Insights, 2014” provides Xanax XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Pristiq-Drug Insights,2014 Pristiq-Drug Insights,2014 - Product Thumbnail Image

Pristiq-Drug Insights,2014

“Pristiq - Drug Insights, 2014” provides Pristiq marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Maxalt-Drug Insights,2014 Maxalt-Drug Insights,2014 - Product Thumbnail Image

Maxalt-Drug Insights,2014

“Maxalt - Drug Insights, 2014” provides Maxalt marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Chantix-Drug Insights,2014 Chantix-Drug Insights,2014 - Product Thumbnail Image

Chantix-Drug Insights,2014

“Chantix - Drug Insights, 2014” provides Chantix marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Lamotrigine GSK-Drug Insights,2014 Lamotrigine GSK-Drug Insights,2014 - Product Thumbnail Image

Lamotrigine GSK-Drug Insights,2014

“Lamotrigine GSK - Drug Insights, 2014” provides Lamotrigine GSK marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the...

February 2015
FROM
Risperdal Consta LP-Drug Insights,2014 Risperdal Consta LP-Drug Insights,2014 - Product Thumbnail Image

Risperdal Consta LP-Drug Insights,2014

“Risperdal Consta LP - Drug Insights, 2014” provides Risperdal Consta LP marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

February 2015
FROM
Eranz-Drug Insights,2014 Eranz-Drug Insights,2014 - Product Thumbnail Image

Eranz-Drug Insights,2014

“Eranz - Drug Insights, 2014” provides Eranz marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.